Stay updated on Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial
Sign up to get notified when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.

Latest updates to the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page
- Check4 days agoChange DetectedThe site footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check11 days agoChange DetectedThe record presents details of the completed belimumab study for emphysema patients, including its eligibility criteria, treatment plan, measured outcomes, and study documents.SummaryDifference51%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedA site-wide notice says NIH agencies are transitioning from “Artificial Intelligence” to “Super Intelligence,” and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe site's displayed revision identifier changed from v3.7.0 to v3.7.1. The study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home button, replacing the study record content. This indicates the trial details are currently inaccessible due to an access restriction or server issue.SummaryDifference19%

Stay in the know with updates to Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.